Open access · OA
via OpenAlex
Intermittent fasting interventions to leverage metabolic and circadian mechanisms for cancer treatment and supportive care outcomes
Faiza Kalam, Dara L. James, Yun Rose Li, Michael F. Coleman, Violet A. Kiesel, Elizabeth M. Cespedes Feliciano, Stephen David Hursting, Dorothy D. Sears, Amber S. Kleckner
JNCI Monographs · 2023 · ▲ 44 citations
Abstract
Intermittent fasting entails restricting food intake during specific times of day, days of the week, religious practice, or surrounding clinically important events. Herein, the metabolic and circadian rhythm mechanisms underlying the proposed benefits of intermittent fasting for the cancer population are described. We summarize epidemiological, preclinical, and clinical studies in cancer published between January 2020 and August 2022 and propose avenues for future research. An outstanding concern regarding the use of intermittent fasting among cancer patients is that fasting often results in caloric restriction(definition), which can put patients already prone to malnutrition, cachexia, or sarcopenia at risk. Although clinical trials do not yet provide sufficient data to support the general use of intermittent fasting in clinical practice, this summary may be useful for patients, caregivers, and clinicians who are exploring intermittent fasting as part of their cancer journey for clinical outcomes and symptom management.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/jncimonographs/lgad008
- Canonical
- link ↗
- Fetched
- 2026-09-28 MST
Cite this
APA
Kalam, F., James, D.L., Li, Y.R., Coleman, M.F., Kiesel, V.A., Feliciano, E.M.C., Hursting, S.D., Sears, D.D., & Kleckner, A.S. (2023). Intermittent fasting interventions to leverage metabolic and circadian mechanisms for cancer treatment and supportive care outcomes. <em>JNCI Monographs</em>. https://doi.org/10.1093/jncimonographs/lgad008
Vancouver
Kalam F, James DL, Li YR, Coleman MF, Kiesel VA, Feliciano EMC, et al. Intermittent fasting interventions to leverage metabolic and circadian mechanisms for cancer treatment and supportive care outcomes. JNCI Monographs. 2023. doi:10.1093/jncimonographs/lgad008.
BibTeX
@article{faiza2023Interm,
title = {Intermittent fasting interventions to leverage metabolic and circadian mechanisms for cancer treatment and supportive care outcomes},
author = {Faiza Kalam and Dara L. James and Yun Rose Li and Michael F. Coleman and Violet A. Kiesel and Elizabeth M. Cespedes Feliciano and Stephen David Hursting and Dorothy D. Sears and Amber S. Kleckner},
journal = {JNCI Monographs},
year = {2023},
doi = {10.1093/jncimonographs/lgad008},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
GeroScience 2021
Preprint · OA
Intermittent fasting: from calories to time restriction
Seminars in Cancer Biology 2020
Preprint · OA
The effect of caloric restriction and fasting on cancer
International journal of applied biology and forensic 2019
Open access · CC-BY
THE SCIENCE BEHIND INTERMITTENT FASTING
Frontiers in Microbiology 2023
Open access · CC-BY
Effects of Ramadan intermittent fasting on gut microbiome: is the diet key?
Timocki medicinski glasnik 2025
Open access · CC-BY
Intermittent fasting: Is it beneficial for health?
European Journal of Clinical Nutrition 2026
Citation only